Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Engagement With Digital Adherence Technologies as Measures of Intervention Fidelity Among Adults With Drug-Susceptible Tuberculosis and Health Care Providers: Descriptive Analysis Using Data From Cluster-Randomized Trials in Five Countries.
Alacapa, J; TADESSE, AW; Deyanova, N; Dube, T; Mganga, A; Powers, R; Van Rest, J; Madden, N; Efo, E; Charalambous, S; Van Kalmthout, K; Jerene, D; FIELDING, K;
2025
JMIR public health and surveillance, (2025).11, 10.2196/62881.
A timeline of reckoning: Tracking the historical rise of antimicrobial resistance across HIV, TB, and malaria.
Williamson, T; Adderley, J; Quinn, K; CLARK, TG; Lewin, SR; Doerig, C;
2025
Journal of global antimicrobial resistance, (2025).44, 10.1016/j.jgar.2025.07.014.
New adult and adolescent tuberculosis vaccines and Indonesia: policy planning and evidence, November 2024.
Alfaqeeh, M; Ewart, S; Tanoto, R; Buenastuti, W; Isturini, IA; Yosephine, P; Burhan, E; Siagian, RC; Hadinegoro, SR; Lenggogeni, D; WHITE, RG; Suwantika, AA; Kasaeva, T; Giersing, B;
2025
Vaccine, (2025).62, 10.1016/j.vaccine.2025.127490.
Implications of reference equations for interpretation of spirometry in three African countries: a cross-sectional study.
Banze, D; CALDERWOOD, CJ; Nhamuave, C; Marambire, ET; Mfinanga, A; LARSSON, L; Malhotra, AM; Minja, LT; Ivanova, O; Zurba, L; Heinrich, N; FERRAND, RA; FIELDING, K; KRANZER, K; Rachow, A; Hurst, JR; Khosa, C;
2025
ERJ open research, (2025).11 4 10.1183/23120541.00932-2024.
Plasma proteomics for biomarker discovery in childhood tuberculosis.
Fossati, A; Wambi, P; Jaganath, D; Calderon, R; Castro, R; Mohapatra, A; McKetney, J; Luiz, J; Nerurkar, R; NKEREUWEM, E; Franke, MF; Mousavian, Z; Collins, JM; Sigal, GB; Segal, MR; Kampman, B; Wobudeya, E; Cattamanchi, A; Ernst, JD; Zar, HJ; Swaney, DL; COMBO Study Consortium,;
2025
Nature communications, (2025).16, 10.1038/s41467-025-61515-5.
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and care.
LEGRAND, KE; Edwards, A; Mohlamonyane, M; Dayi, N; Olivier, S; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K; KHAN, P; MCCREESH, N;
2025
PLOS global public health, (2025).5 7 10.1371/journal.pgph.0004257.
Blood RNA biomarkers and C-reactive protein for triage of adult patients with tuberculosis lymphadenitis and pericarditis in South Africa: a single-centre, prospective, observational, diagnostic accuracy study.
Mann, T; Minnies, S; Gupta, RK; Reeve, BW P; Nyawo, G; Palmer, Z; Naidoo, C; Doubell, A; Pecoraro, A; John, T-J; Schubert, P; CALDERWOOD, CJ; Chandran, A; Theron, G; Noursadeghi, M;
2025
The Lancet. Microbe, (2025).6 9 10.1016/j.lanmic.2025.101153.
Risk of rifampicin resistance emergence after incomplete first-line tuberculosis treatment.
Dupuis, GN; Dolynska, M; Chiang, SS; Horsburgh, CR; STAGG, HR; Rybak, NR; Petrenko, V; Jenkins, HE;
2025
European respiratory journal, (2025).66 1 10.1183/13993003.00902-2025.
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study.
CLARK, RA; MCQUAID, CF; Richards, AS; Bakker, R; SUMNER, T; Prŷs-Jones, TO; HOUBEN, RM G J; WHITE, RG; HORTON, KC;
2025
The Lancet Global health, (2025).13 9 10.1016/S2214-109X(25)00232-3.
PPE50 variants as novel phylogeographic signatures of host-pathogen co-evolution in tuberculosis.
D'Souza, C; PHELAN, JE; Gomez-Gonzalez, P-J; THORPE, J; CLARK, TG; Tsolaki, AG;
2025
Communications biology, (2025).8 1 10.1038/s42003-025-08383-3.